CGRP antagonists in the acute treatment of migraine

Lancet Neurol. 2004 Jun;3(6):332. doi: 10.1016/S1474-4422(04)00764-1.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acute Disease
  • Calcitonin Gene-Related Peptide / antagonists & inhibitors*
  • Calcitonin Gene-Related Peptide / metabolism
  • Cerebral Arteries / drug effects
  • Cerebral Arteries / innervation
  • Cerebral Arteries / physiopathology
  • Humans
  • Migraine Disorders / drug therapy*
  • Migraine Disorders / metabolism
  • Migraine Disorders / physiopathology
  • Piperazines / pharmacology*
  • Piperazines / therapeutic use
  • Quinazolines / pharmacology*
  • Quinazolines / therapeutic use
  • Trigeminal Nerve / drug effects
  • Trigeminal Nerve / metabolism
  • Trigeminal Nerve / physiopathology
  • Vasoconstriction / drug effects
  • Vasoconstriction / physiology
  • Vasoconstrictor Agents / adverse effects

Substances

  • Piperazines
  • Quinazolines
  • Vasoconstrictor Agents
  • Calcitonin Gene-Related Peptide
  • olcegepant